Broadcast Date: 
  • Time: 

Recent technical advances allow investigators to analyze clinical samples with robust high-throughput proteomic workflows, creating an opportunity to analyze large numbers of patient samples during the COVID-19 pandemic. These new workflows also afford investigators the unique opportunity to analyze individual patient tissue proteomes in three dimensions. In this GEN webinar, our esteemed presenter, Dr. Roman Fischer from the University of Oxford, will showcase the application and limitations of high-throughput timsTOF Pro mass spectrometry on large scale clinical sample sets in order to stratify patients and contribute to a multi-omics blood atlas of COVID-19 patients, and the combination of laser capture microdissection with proteomics methods for the 3D characterization of large biological macrostructures such as organs or tumors. Additionally, our second distinguished speaker, Prof. Catherine C.L. Wong from Peking University, will discuss how she is using quantitative proteomics to study the suppression of the human immune system during the early stages of COVID-19.

A live Q&A session followed the presentations, offering a chance to pose questions to our expert panelists.

*For Research Use Only. Not for use in clinical diagnostic procedures.


Roman Fischer, PhD
Roman Fischer, PhD
Associate Professor in Clinical Proteomics
Target Discovery Institute
University of Oxford
Catherine C.L. Wong, PhD
Director, Center for Precision Medicine
Multi-omics Research
Peking University

Bruker logo